- Home
- PHAR vs SGML Comparison
PHAR vs SGML Comparison
Compare PHAR & SGML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAR
- SGML
- Stock Information
- Founded
- PHAR 1988
- SGML 2011
- Country
- PHAR Netherlands
- SGML Brazil
- Employees
- PHAR N/A
- SGML N/A
- Industry
- PHAR Biotechnology: Pharmaceutical Preparations
- SGML Industrial Machinery/Components
- Sector
- PHAR Health Care
- SGML Industrials
- Exchange
- PHAR Nasdaq
- SGML Nasdaq
- Market Cap
- PHAR 798.2M
- SGML 743.4M
- IPO Year
- PHAR N/A
- SGML N/A
- Fundamental
- Price
- PHAR $13.70
- SGML $6.12
- Analyst Decision
- PHAR Strong Buy
- SGML Strong Buy
- Analyst Count
- PHAR 3
- SGML 2
- Target Price
- PHAR $30.00
- SGML $18.00
- AVG Volume (30 Days)
- PHAR 12.8K
- SGML 3.4M
- Earning Date
- PHAR 07-31-2025
- SGML 08-15-2025
- Dividend Yield
- PHAR N/A
- SGML N/A
- EPS Growth
- PHAR N/A
- SGML N/A
- EPS
- PHAR N/A
- SGML N/A
- Revenue
- PHAR $339,836,000.00
- SGML $134,494,014.00
- Revenue This Year
- PHAR $12.88
- SGML N/A
- Revenue Next Year
- PHAR $8.54
- SGML $42.31
- P/E Ratio
- PHAR N/A
- SGML N/A
- Revenue Growth
- PHAR 22.44
- SGML N/A
- 52 Week Low
- PHAR $6.73
- SGML $4.25
- 52 Week High
- PHAR $17.08
- SGML $15.56
- Technical
- Relative Strength Index (RSI)
- PHAR 67.43
- SGML 52.63
- Support Level
- PHAR $12.13
- SGML $5.80
- Resistance Level
- PHAR $12.76
- SGML $7.39
- Average True Range (ATR)
- PHAR 0.89
- SGML 0.53
- MACD
- PHAR 0.13
- SGML 0.03
- Stochastic Oscillator
- PHAR 44.41
- SGML 48.37
About PHAR Pharming Group N.V.
Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.
About SGML Sigma Lithium Corporation
Sigma Lithium Corp together with its direct and indirect subsidiaries, is a commercial producer of lithium concentrate. It holds a 100% interest in four mineral properties: Grota do Cirilo, Sao Jose, Santa Clara, and Genipapo, located in the municipalities of Aracuai and Itinga, in the Vale do Jequitinhonha region in the State of Minas Gerais, Brazil.